Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous plasma (1 trial)
betaine (1 trial)
choline c11 (choline c-11) (1 trial)
cyanocobalamin (berocca) (1 trial)
icosapent ethyl (vascepa) (1 trial)
linolic acid (1 trial)
n5-methyltetrahydropteroylglutamate (1 trial)
chokeberry extract (1 trial)
vitamin c (1 trial)
Dyslipidemias (Phase 2)
Trials (4 total)
Trial APIs (9 total)